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Abstract 
Background: The design of efficient drug delivery vectors requires versatile formulations able to simultaneously 
direct a multitude of molecular targets and to bypass the endosomal recycling pathway of cells. Liposomal‑based 
vectors need the decoration of the lipid surface with specific peptides to fulfill the functional requirements. The 
unspecific binding of peptides to the lipid surface is often accompanied with uncontrolled formulations and thus 
preventing the molecular mechanisms of a successful therapy.
Results: We present a simple synthesis pathway to anchor cysteine‑terminal peptides to thiol‑reactive lipids for ade‑
quate and quantitative liposomal formulations. As a proof of concept, we have synthesized two different lipopeptides 
based on (a) the truncated Fibroblast Growth Factor (tbFGF) for cell targeting and (b) the pH sensitive and fusogenic 
GALA peptide for endosomal scape.
Conclusions: The incorporation of these two lipopeptides in the liposomal formulation improves the fibroblast cell 
targeting and promotes the direct delivery of cargo molecules to the cytoplasm of the cell.
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Background
Liposomes have been extensively used as delivery vectors 
for pharmaceuticals as they have a series of advantages 
over other molecular release systems [1]. Liposomes are 
non-toxic, and completely biodegradable and do not 
exhibit immunogenicity [2]. Their phospholipid bilayer 
envelope provides both hydrophobic and hydrophilic 
moieties for a diverse kind of active cargo molecules, 
increasing their stability and reducing their toxicity. In 
addition, liposomes are versatile scaffolds with tunable 
physicochemical properties. The thousands of lipid spe-
cies [3] can be used to tailor the specific requirements 
for improved delivery. Spontaneous curvature [4], bend-
ing rigidity [5], dilational elasticity [6], membrane fluidity 
[7] or surface charge [1] are easily controlled through the 
lipid composition.
The controlled and selective delivery of compounds 
into cells is a key element of targeted drug delivery thera-
pies. Major innovations in liposome technology were 
achieved by triggered-release strategies using activating 
sources such as pH, ultrasound, heat or light [8, 9]. The 
drug release can be time regulated and locally restricted 
to specific sites with suitable formulations including 
externally switchable molecules. In practice, they are, 
however, been difficult to engineer. The new genera-
tion of smart liposomes takes advantage instead of well-
controlled biochemical switches already provided by the 
targeted cells. This implies the surface modification of 
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liposomes with passive or active targeting approaches 
and improved intracellular delivering systems [1].
A paradigmatic strategy of passive targeting consists 
on the incorporation of PEGylated lipids in the lipo-
somal composition to avoid the detection by the host 
immune system [10]. PEG-grafted liposomes improve 
the residence time in the blood circulation, as compared 
to conventional liposomes [11]. Active targeting is based 
on cellular receptors that are found on surface of the 
target cell and demands the modification of the liposo-
mal surface with specific molecules able to recognize or 
bind the present surface receptors. After cellular uptake, 
liposomes are usually trapped in endosomes [12, 13] and 
not able to release their therapeutic cargos within the 
cell. Numerous formulations take advantage of the acidic 
medium of the endosomes and include specialized pH-
dependent fusion peptides to promote endosomal escape 
[14–16]. Combined strategies improve simultaneously 
the ability of liposomes to accumulate on the target cell 
and the uptake of the active drug in the lumen of the cell 
[17].
The surface functionalization of liposomes is an impor-
tant step to improve their delivery efficiency. The very 
reactive sulfhydryl group of cysteine amino acid residues 
allows the conjugation of cysteine containing-peptides 
through classical sulfhydryl-reactive crosslinkers or thiol 
reagents. The thiol is susceptible to oxidation promot-
ing the formation of a thioether or disulfide bonds. The 
first reaction can be achieved with high concentration of 
maleimides following a Michael addition reaction to form 
succinimide thioethers derivatives or in the presence of 
haloacetyls (iodoacetimide) reagents following nucleo-
philic substitution [18]. However, the succinimide bond 
can be hydrolyzed spontaneously thus losing the binding 
between the peptide and the ligand [19]. Peptide biocon-
jugation based on the formation of disulfide bonds, where 
the cysteine groups react with pyridyl disulfides reagents, 
produces a labile disulfide bond in both redox and hydro-
lytic conditions but only potentially cleaved due to action 
of thioreductases enzymes in biological contexts [20].
Here we present a straightforward synthesis pathway to 
anchor peptides with terminal cysteine residues to sulfy-
dryl-reactive lipids for adequate and quantitative liposo-
mal formulations. Based in the pyridyl disulfide reaction 
chemistry [21], we have functionalized lipids with (a) a 
truncated Fribloblast Growth Factor (FGF) for cell tar-
geting and (b) a pH sensitive fusogenic peptide (GALA) 
for endosomal escape. The basic fibroblast growth factor 
(bFGF) is one of the 23 multifunctional proteins belong-
ing to the family of fibroblast growth factors that binds to 
the FGF surface membrane receptors (FGFRs) [22] and 
widely used as a targeting molecule due to its mitogenic, 
chemotactic and angiogenic activities promoting the 
rapid proliferation of cells. The truncated bFGF (tbFGF) 
is a 9-amino acid peptide that includes a cysteine in the 
carboxy terminal end (NH2-KRTGQYKLC-COOH) [23] 
and although it is able to bind to FGFRs it is not able to 
induce cell proliferation [24–26].
The GALA peptide (NH2-WEAA-LAEA-LAEA-LAE-
H-LAEA-LAEA-LEALAA-COOH) is a member of the 
pH-sensitive peptide family [27, 28] and originates from 
the amino terminal segment of the H2A subunit of 
hemagglutinin from the influenza virus [25, 29, 30]. At 
low pH (i.e. pH = 5) the GALA peptide organizes into 
an amphipathic alpha helix partitioning the amino acid 
side chains into a hydrophilic or a hydrophobic surface. 
This reorganization promotes the self-oligomerization of 
10 peptides [31] that is able to penetrate into the hydro-
phobic core of lipid membranes forming pores with a 
diameter of 5–10  Å [17, 25]. At physiological and basic 
pH (pH > 7) the GALA peptide presents a random coil 
configuration and exhibits no membrane activity [28]. 
Triggered by the acidic medium within the lumen of the 
endosomes, it has been shown that GALA effectively 
penetrates and permeates cell lipid bilayers and allows 
the endosomal escape during the internalization of drugs 
into the cytosol via endocytosis [28, 31].
As a proof of concept, our results show that the incor-
poration of both synthesized bioconjugated lipopeptides 
in liposomal formulations improved the cell targeting 
and promoted the direct delivery of cargo molecules in 
the cytosolic moiety of cultured mouse embryonic fibro-
blasts (MEFs).
Results
Lipid–peptide conjugation through pyridyl disulfide 
reaction chemistry
The cysteine-containing tbFGF and a variant of the 
GALA peptide (GALA-Cys, carrying the cysteine resi-
due at the carboxy terminal end) were conjugated to 
the thiol-reactive lipid 1,2-dipalmitoyl-sn-glycero-
3-phospho-thio-ethanol (DPTE) accomplished with 
two pyridyl disulfide exchange reactions (Fig.  1). A first 
disulfide exchange occurs between 2-2-pyridyl disulfide 
(DPDS) and the thiol group of DPTE in acidic condi-
tions (see “Methods”). After purification of the acti-
vated DPTE (aDPTE), the disulfide bridge formed by 
DPTE and 2-mercaptopyridine is substituted by DPTE 
and the cysteine-containing peptide at molar ratio of 1:2 
(DPTE:peptide-SH) (see “Methods”). Although the opti-
mal pH for disulfide exchange ranges from 4 to 5, the 
second disulfide exchange was performed at alkaline pH 
9, above the pKa of cysteine residues (Additional file  1: 
Figure S1), to force the cysteine residue of the peptides 
to react. Furthermore, the reaction was performed in a 
mixture of tetrahydrofuran (THF) and 1 M Tris HCl pH 
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9 (2:1; vol:vol) under stirring conditions for 48 h at 20 °C 
in the dark. This solvent mixture ensures the solubil-
ity of both the hydrophobic lipids and the charged pep-
tides in a buffered medium. The course and progress of 
this reaction can be measured spectrophotometrically 
 (Amax = 363  nm) monitoring the release of the byprod-
uct pyridine-2-thione [32]. The disulfide exchange takes 
place within the first 10  min where the reaction kinetic 
reaches a pseudo-plateau indicating a slower reaction 
rate (Additional file 1: Figure S2A). The reaction mixture 
was left up to 48 h in the dark to fully complete the reac-
tion. After purification of the DPTE-peptide, the reaction 
intermediates and final products were dissolved in deu-
terated chloroform and characterized by 1H NMR spec-
troscopy (see Additional file 1: Figure S2B and “Methods” 
for details). Finally, the lipid to protein ratio of the lipo-
peptide conjugation was determined by Rouser [33] and 
Lowry [34] assays respectively (see “Methods” for details) 
giving a 100% and 95% conjugation efficiency for the 
DPTE-tbFGF and DPTE-GALA respectively.
POPC vesicles containing DPTE‑tbFGF and DPTE‑GALA
To characterize the lipid concentration, the lipopeptide 
molar fraction, the size and the stability of liposomes, dif-
ferent molar ratios of DPTE-tbFGF and/or DPTE-GALA 
were incorporated into pure POPC vesicles. As some 
lipid loss might occur during extrusion [35], the lipid 
concentration was quantified before and after extrusion 
down to the size of 0.1  µm. The phosphorous analysis 
[33] did not detect significant loss of lipids during lipo-
some preparation, as shown in Additional file 1: Table S1. 
Similarly, the molar fraction of lipopeptides was not 
altered during extrusion (Additional file 1: Table S1). The 
results obtained from the size characterization are shown 
in Fig. 2a. The light scattering results show that the incor-
poration of DPTE-tbFGF and DPTE-GALA in POPC 
liposomes does not affect substantially the size of the 
liposomes. All formulations had mean diameters around 
150–200  nm immediately after extrusion and retained 
this size for several days. This indicates that no fuso-
genic nor aggregating activity of peptides is occurring at 
pH 7.4. However, the surface charge of POPC liposomes 
(~ 0 mV) is altered upon incorporation of the negatively 
charged peptides and a decrease in the ζ-potential is evi-
denced (≤ 20 mV) (Fig. 2b).
Cell viability upon liposomal incubation with different 
molar ratios of DPTE‑tbFGF and DPTE‑GALA
We use the alamarBlue cell viability assay to assess the 
cell viability of mouse embryonic fibroblasts (MEFs) 
exposed to POPC liposomes at 50, 75 and 100  μM and 
decorated with different molar ratios of the lipid–peptide 
conjugates (DPTE-tbFGF and DPTE-GALA). Figure  3 
shows the cell viability results for different molar ratios of 
the DPTE-peptide conjugates at 50, 75 and 100 μM lipo-
some concentration. None of the used lipid compositions 
or liposomal concentrations explored showed a signifi-
cant effect on cell viability (p value < 0.05). In general, the 
liposomes do not induce a significant cell death (> than 
20% in extreme cases) nor do they stimulate the prolif-
eration of MEFs. Overall, both DPTE-peptide conjugates 
are biocompatible, not harmful for cell viability, and thus 
safe to use for ex vivo MEF cultures. For following experi-
ments with cultured MEFs we fixed the liposome concen-
tration at 100 μM.
Liposomal uptake of tbFGF‑coated liposomes by cultured 
MEFs
We first tested the increased uptake of tbFGF-coated 
POPC liposomes in cultured MEFs. MEFs were incu-
bated with POPC liposomes presenting 0, 1, 5 and 
10% molar of the targeting DPTE-tbFGF to evaluate 
Fig. 1 Two‑step lipid–peptide conjugation through pyridyl disulfide reaction chemistry. Lipid activation (Step 1, left) DPTE lipid is activated with 
mercaptopyridine to avoid non‑specific unwanted reaction products, i.e. the formation of the symmetric DPTE disulfide. Lipid bioconjugation (Step 
2, right): the activated DPTE react with the sulfhydryl‑group of the peptide of interest
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the optimal liposome formulation for a specific uptake 
mediated by the tbFGF. To visualize and trace liposomes 
inside MEFs by means of confocal fluorescence 
microscopy, calcein at a final concentration of 100 mM 
was encapsulated in the lumen of liposomes during 
liposome preparation (see “Methods”). MEFs were 
Fig. 2 a Hydrodynamic diameter of POPC/DPTE‑GALA/DPTE‑tbFGF liposomes at different lipo‑peptide molar ratios. b Zeta potential of POPC/
DPTE‑GALA/DPTE‑tbFGF liposomes at different lipo‑peptide molar ratios. Measurements are are representative of seven repeated experiments
Fig. 3 Cellular viability of mouse embryonic fibroblasts exposed to POPC liposomes decorated with DPTE‑tbFGF and DPTE‑GALA. MEFs were 
exposed to 50, 75 or 100 μM of DPTE‑tbFGF and DPTE‑GALA decorated POPC liposomes for 24 h at 37 °C and cell viability is assessed with the 
Alamar Blue reagent. The % mol ratios of DPTE‑tbFGF and DPTE‑GALA on the POPC liposomes are indicated in the figure (see main text for details)
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imaged at 2, 4 and 6 h after liposome incubation. After 
2 h of incubation (early uptake) liposome uptake can be 
observed for liposomes carrying 10% of DPTE-tbFGF. 
A low green fluorescence signal was also observed in 
cells treated with lower DPTE-tbFGF concentrations 
(1% or 5%) (Fig.  4, left column). After 4  h of incuba-
tion, liposome uptake is observed for all formulations 
used (Fig.  4, central column). At 6  h, the green level 
is increased for the lipid formulation carrying 10% of 
DPTE-tbFGF showing a high liposomal uptake. At this 
time point MEFs incubated with liposomes carrying 
1% or 5% of DPTE-tbFGF reached comparable fluo-
rescence intensity signals (Fig. 4, right column). For all 
tested conditions, control cells incubated with non-
decorated bare POPC liposomes show very little, non-
directed vesicle uptake, background in time (data not 
shown). We conclude that the presence of the DPTE-
tbFGF in our liposome formulation improves the spe-
cific liposome uptake of MEFs.
Endosomal escape of tbFGF‑ and GALA‑coated liposomes
To evaluate the fusogenic activity of DPTE-GALA conju-
gate, we first performed classical fluorescence liposome 
fusion assays with GALA-coated liposomes (1 and 5 
molar ratios) carrying calcein at a self-quenching concen-
tration of 100  mM (see “Methods”). The GALA-coated 
liposomes were mixed with bare and non-fluorescent 
liposomes. Liposome fusion leads to a dilution of lume-
nal calcein concentration and to an increase of the calcein 
fluorescence signal. Signal increase is proportional to the 
liposome fusion activity. At pH 5.5 an increase in fluo-
rescence signal of GALA-coated liposomes was observed 
indicating liposome fusion (Fig.  5a). The velocity of the 
observed fusion events depends on the molar amount of 
DPTE-GALA (1% or 5%) attached to the liposome sur-
face. At pH 8, no calcein release was observed, neither 
for the presence of 1% nor 5% DPTE-GALA, whereas the 
addition of the detergent Triton-X100 completely solubi-
lized the liposomes and released the total encapsulated 
calcein content.
Fig. 4 Confocal microscopy images of peptide‑decorated POPC liposome uptake by mouse embryonic fibroblasts. MEFs exposed for 2, 4 and 6 h 
to 100 µM of calcein‑loaded DPTE‑tbFGF decorated POPC liposomes. The calcein fluorescence was imaged in the green channel with a bandpass of 
515 to 555 nm (see main text for details). Scale bar is 10 μm
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We then evaluated the fusogenic activity of DPTE-
GALA inside MEFs. To visualize and trace the calcein 
release inside MEFs with confocal fluorescence micros-
copy, the cells were incubated with Lysotracker™ Red and 
then incubated with 100 μM POPC liposomes filled with 
calcein at 100 mM and decorated with 10% mol DPTE-
GALA. After 12  h, the liposome uptake is observed as 
the fluorescence intensity of both lysosomal and cal-
cein channels partially colocalize. We also observe cal-
cein fluorescence in the cytoplasm of MEFs suggesting 
the endosomal escape of GALA-coated liposomes from 
the endosomal system. For comparison, bare POPC 
liposomes only displayed colocalization of the green and 
the red fluorescence signals of the liposomes trapped in 
the endosomal system of the cell. We conclude that the 
liposome uptake in MEFs is produced via the endosomal 
pathway and the calcein content is released by the action 
of the GALA lipopeptide (Fig. 5b).
Efficient ATP delivery into MEFs
ATP is the biochemical energy of the cell and is required 
as many processes in cells are driven, either directly or 
Fig. 5 Liposome fusion assay of GALA‑decorated POPC liposomes. a Fusion assay of GALA‑decorated POPC liposomes at pH 8 and pH 5.5. 
The fusion was monitored through the change of the fluorescence intensity form encapsulated calcein at a self‑quenching concentration of 
100 mM. Total calcein release was monitored by the addition of Triton X‑100 and non‑decorated POPC liposomes were used as control. b Confocal 
microscopy images of MEFs exposed for 6 h to 100 µM of calcein‑loaded 10% of DPTE‑GALA decorated POPC liposomes at 37 °C stained with 
Lysotraker™ RED. The Lysotraker fluorescence was imaged in the red channel. Scale bars are 10 μm
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indirectly, by the hydrolysis of ATP. Alteration of ATP 
biogenesis may cause a variety of severe mitochondrial 
disorders [36]. Classical pharmacological approaches 
that address the increase of the cellular levels of ATP 
are based on the stimulation of the de novo synthesis of 
ATP in situ [37] as the intravenous injection of ATP does 
not result in desired results because of the very short 
half-life of free blood circulating ATP [38]. Here, we test 
direct administration of ATP charged POPC liposomes 
[39] decorated with 10% mol DPTE-tbFGF and 10% mol 
DPTE-GALA.
MEFs were first tested for the uptake of free ATP and 
incubated with increasing amounts of ATP (1, 2.5, 5 
and 10 mM) and harvested after 6 and 24 h (see “Meth-
ods”). The ATP delivery in cultured MEFs was quanti-
fied with Luciferin/Luciferase based bioluminescence 
assay. Compared to untreated control cells, the results 
show a 20–40% increase of the cellular ATP level after 
6 h of ATP incubation depending on the amount of ATP 
added to the cell culture (Fig. 6a). At 24 h, the incubation 
resulted in a cellular ATP level (up to fivefold increase 
for 10 mM ATP), but the cell viability of these cells was 
severely compromised suggesting that high extracellular 
ATP concentrations induce cytotoxic side effects includ-
ing the compromising of the cell integrity (Additional 
file 1: Figure S3).
After the optimization of the minimal concentration 
of ATP required its encapsulation into POPC liposomes 
carrying 10% mol of DPTE-tbFGF and 10% mol of 
DPTE-GALA (Additional file  1: Figure S4), MEFs were 
incubated for 6 h with POPC liposomes containing 10% 
mol of DPTE-tbFGF and increasing amounts of DPTE-
GALA (0, 5 and 10% mol) and loaded with 50 mM ATP. 
After 6 h of incubation, the liposomes were washed with 
fresh DMEM media and the intracellular ATP levels 
were quantified after 12 h. Our data show that the intra-
cellular delivery of ATP is concentration-dependent on 
DPTE-GALA (Fig. 6b). Again, the formulation of POPC 
liposomes carrying 10% mol of DPTE-tbFGF and 10% 
mol of DPTE-GALA shows an improved uptake of the 
ATP into the cells, reaching a maximum change of ≈ 1.5-
fold compared with untreated control cells.
Protein encapsulation and release into MEFs
To unambiguously demonstrate the delivery efficiency 
of tbFGF- and GALA-decorated liposomes, cell viabil-
ity was verified upon incubation with liposomes encap-
sulating the potent 30  kDa saporin-S6 toxin (saporin). 
Saporin enzymatically inactivates the ribosomes leading 
to a block in de novo protein synthesis, resulting in the 
cell death [40, 41]. When the MEFs were exposed to 10 
or 100 µg/ml of non-encapulated saporin, ∼ 50 to 60% of 
a cell death was observed after 8 and 48 h of incubation 
respectively. However, 30 to 35% of cell death was pro-
duced when the toxin was administered in “bared” POPC 
liposomes. Remarkably, the presence of 10% mol DPTE-
GALA and DPTE-tbFGF progressively decreased the cell 
viability and killed 75% of the cells after 48 h of incuba-
tion (Fig. 7).
The cytosolic delivery of saporin was further confirmed 
by scanning confocal fluorescence microscopy. MEFs 
were labelled with the mitochondrial marker Rho123. 
Over time, the normal mitochondrial network of MEFs 
remained unaltered in the absence of treatment. In con-
trast, when non-encapsulated saporin was extracellularly 
supplemented to the medium and delivered into cells 
or administered through liposomes, a significant cell 
shrinkage and a change in mitochondrial morphology, 
Fig. 6 ATP delivery into mouse embryonic fibroblasts. The change of the cellular ATP concentrations in MEFs upon exposure to a free ATP or b 
DPTE‑tbFGF‑ and DPTE‑GALA containing POPC liposomes with encapsulated ATP. In this case, MEFs were incubated for 6 h at 37 °C and the cellular 
ATP levels were measured after 12 h with Luciferin/Luciferase based assay (see main text for details)
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indicating cell death, was observed (inset in Fig. 7). These 
results collectively demonstrate that DPTE-based lipo-
peptides allows the delivery of proteins without the loss 
of functionality into the cytosol of eukaryotic cell.
Discussion
In drug delivery, the development of experimental tech-
niques for the effective release of liposomal contents 
through endosomal and lysosomal membranes is key to 
prevent their degradation through the endosomal matu-
ration pathway before reaching cytosolic moiety of the 
cell. Our finding, a peptide decorated liposome formula-
tion, allows the specific cellular uptake and the escape of 
the luminal content from the endosomal system for effi-
cient drug delivery.
In this work we used two peptides, the tbFGF and 
GALA to control the efficient cellular uptake and endo-
somal escape of our POPC liposome vector respectively. 
The tbFGF peptide is a truncated version of the fibro-
blast growth factor (FGF) that plays an important role 
in tumor growth and angiogenesis [42–44]. This pep-
tide binds to the bFGF receptor but does not stimulate 
cell proliferation [45]. Endocytosis is the major pathway 
for the tbFGFp mediated cellular uptake of liposomes for 
cell-to-cell communication and their use in drug delivery 
[22, 46–51]. The GALA peptide was designed to mimic 
viral fusion protein sequences that interact with cell 
membranes to mediate the escape of the viral genes from 
acidic endosomes [28]. The application of the GALA pep-
tides is well studied and used in gene transfection [52–57] 
and the cytosolic delivery of peptides and proteins [47]. 
In more detail, we conjugated DPTE to the cysteine pep-
tides tbFGF and GALA-Cys prior to lipid vesicle prepara-
tion. The lipopeptide synthesis method (Fig. 1), based in 
the pyridyl disulfide reaction chemistry [21], is character-
ized by high yields and very easy purification procedures 
and differs from previously reported cysteine conjugation 
methods [19], which result in succinimide bonds that can 
be hydrolyzed spontaneously and give thus in very low 
coupling efficiencies. Our approach relies on the forma-
tion of a pre-conjugated nano-sized peptide-lipid system 
prior to their incorporation into the liposomes; whereas 
most of previous works dealt with some thiol-reactive 
polymers [58–60] or pre-formed nano-objects [21, 61, 
62] that were designed to react with the cysteine resi-
due of the targeted peptide or protein. Despite the high 
Fig. 7 Saporin toxin delivery into mouse embryonic fibroblasts. Cellular viability of MEFs as a function of time upon saporin incubation 
extracellularly delivered into cells or administered with liposomes decorated with DPTE‑tbFGF and DPTE‑GALA. (Inset) Confocal microscopy images 
of MEFs exposed for 24 h at 37 °C to saporin (10 and 100 μg/ml) and DPTE‑tbFGF‑ and DPTE‑GALA containing POPC liposomes with encapsulated 
saporin (nominal concentration 75 μg/ml). The Rho123 fluorescence was imaged in the green channel. Scale bars are 10 μm
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versatility of the thiopyridyl group, its reactivity depends 
on three main parameters: i.e. the size of the object bear-
ing the disulfide function, the size of the molecule bear-
ing the thiol group and the pH value [63]. Also, the steric 
hindrance of the thiol group has been found to be crucial 
as the kinetics of the thiol-disulfide exchange is drasti-
cally affected when a small thiol-bearing substrate was 
replaced by a larger one [63]. It has been also reported 
that the conjugation of liposomes with proteins might 
lead to liposome aggregation and/or a mixture of labeled 
and unlabeled liposomes that was difficult to resolve 
[64]. Our approach is thus suitable to functionalize lipids 
prior to liposome formation. To our knowledge, only few 
reports [65] follow the same strategy as ours. The advan-
tage of our method resides on the easy modulation and 
control of the amount of lipopeptides to be incorporated 
into the liposomes.
Moreover, DPTE is commercially available and pro-
vides a stable membrane anchoring of peptides to the 
lipid bilayer in comparison with single fatty acid chain 
derivatives. The resulting lipopeptides are soluble in 
organic solvents such as methanol or chloroform and 
can be incorporated into liposomes in the same manner 
as common phospholipids. This allows the controlled 
surface decoration and the controlled mixing of dif-
ferent peptides on the liposome surface without loss of 
peptide functionally and ensures the peptide anchoring 
to the lipid bilayer without impairing the stability and 
size of liposomes (Fig. 2a). In particular, we demonstrate 
the pH-dependent fusogenic properties of liposomes 
containing DPTE-GALA in a physiologically relevant 
pH-range (Fig.  5a). The liposomes can fuse with stable 
target liposomes with a size that mimics the endosomal 
vesicles in cells. The lipopeptide DPTE-GALA presents 
similar characteristics of GALA lipopeptides previously 
described in the literature, where two myristoyl chains 
were attached to the end of GALA through 1,2-diamino 
propanoic acid, yielding the lipopeptide DMDGALA 
[66]. The pH-dependent fusion of DPTE-GALA contain-
ing liposomes allows them to be used for drug delivery 
applications. To this end, the effects of adding the target-
ing lipopeptide DPTE-tbFGF to the liposome surface was 
investigated. The combined addition of different DPTE-
based lipopeptides (up to 20% mol of liposome composi-
tion) might compromise cell viability. However, we have 
found that the action of both DPTE-peptides are biocom-
patible and does not produce cytotoxicity (Fig. 3).
To establish the optimal formulation for efficient cellu-
lar uptake and drug release, MEFs were exposed to POPC 
liposomes decorated with 0 to 10% of DPTE-tbFGF and/
or DPTE-GALA and incubated for 6  h at 37  °C. Con-
focal microscopy imaging shows the effective cellular 
uptake of calcein-loaded liposomes and the cytosolic 
release of its content. An enhanced uptake is observed 
with increasing amounts of DPTE-tbFGF (Fig.  4) and 
no significant cytosolic spread of calcein was observed 
in the absence of DPTE-GALA (Fig.  5). These observa-
tions strongly suggest the involvement of endocytosis in 
the cellular uptake. Additional experiments inhibiting 
the cellular uptake are required to quantitatively ascer-
tain the importance of endosomal pathway and ulterior 
acidification in this targeting system. At low temperature 
(4  °C) the energy-driven processes including endocyto-
sis are suppressed and the presence of ammonium chlo-
ride, prevents endosomal acidification [67]. Nonetheless, 
liposomes attaching GALA are proficient for membrane 
disruption at low pH in living cells. This was previously 
shown in vitro for GALA attached to a flat gold surface 
[68]. In our case, an increase in DPTE-GALA in the 
presence of 10% mol DPTE-tbFGF, led to a faster cyto-
solic delivery of calcein, however we did not quantify 
the efficiency of the delivery. No significant cytotoxicity 
was observed during these incubations even when both, 
DPTE-tbFGF and DPTE-GALA were present up to 10% 
mol. However, a larger excess of both DPTE-GALA and 
DPTE-tbFGF does not necessarily yield to an increased 
and more efficient cytosolic drug release. The excess of 
DPTE-GALA might even increase the negative charges 
on the liposomal surface (Fig. 2b) and interfere with spe-
cific DPTE-tbFGF mediated cellular uptake [57]. We did 
not investigate the fate of the liposome components after 
drug delivery, but expect them to be degraded and com-
pletely cleared from the cells [69].
For a supplementary piece of evidence of quantitative 
delivery, we loaded liposomes with ATP and monitor the 
cellular ATP levels. After incubation with peptide-coated 
liposomes, we were able to increase the ATP levels in 
MEFs (Fig. 6). The addition of extracellular (non-capsu-
lated) ATP to cell cultures is known to be toxic at high 
concentrations [70], thus encapsulation might allow effi-
cient cytosolic delivery of ATP without the need of de 
novo synthesis. The presence of both tbFGF as well as the 
GALA is essential for the efficient cytoplasmic release 
of ATP. This preliminary data indicates that our formu-
lation might be a favorable combination needed for effi-
cient cytosolic targeting and release. However, the ATP 
quantification is carried out after cell lysis and therefore 
the endosomal contents might be released during manip-
ulation and the quantification biased. A concluding 
demonstration of the delivery efficiency of tbFGF- and 
GALA-coated liposomes came from the encapsulation 
and the release of saporin toxin that blocks the de novo 
protein synthesis by inactivating the ribosomes in the 
cytosol. Our results (Fig.  7) demonstrate an enhanced 
cytotoxicity when the toxin was delivered through 
liposomes enriched in DPTE-GALA and DPTE-tbFGF as 
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compared to controls. In contrast to a single dose of high 
concentrated saporin, the combined action of lipopetides 
might mediate a progressive release of the saporin toxin 
producing a gradual enhanced cytotoxicity that might 
counterbalance the gradual cell recovery eventually lead-
ing to a higher cell death (Fig. 7).
Overall, the optimal combination of POPC liposomes 
enriched with DPTE-GALA and DPTE-tbFGF (molar 
ratios of 8:1:1) was important to attain an effective bal-
ance of internalization and cytosolic release and was 
found to be biocompatible in mouse embryonic fibro-
blasts. The success of our liposome formulation can be 
attributed to the presence of DPTE, a thiol-containing 
lipid that can efficiently be incorporated into biological 
membranes [71, 72].
Conclusion
We used a straightforward methodology for the formu-
lation of peptide-decorated liposomes to ensure the effi-
cient enhanced cellular uptake and cytosolic release of 
encapsulated cargo. The targeted peptide tbFGF and the 
pH-sensitive fusogenic peptide GALA were conjugated 
via cysteine residue to the thiol-containing phospho-
lipid DPTE prior to vesicle preparation. Although further 
studies are needed for more advanced and fine-tuned 
control of the cellular uptake and cytosolic release inside 
live cells, our formulation strategy will greatly contribute 
to the application of drug delivery to assess therapeutic 
remedies to cells with pathological phenotypes.
Methods
Lipids, fluorescent probes, peptides and toxin
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
(POPC), and 1,2-dipalmitoyl-sn-glycero-3-phospho-
thioethanol (DPTE) were supplied by Avanti Polar Lipids. 
The peptides NH2-KRTGQYKLC-COOH and NH2-
WEAA-LAEA-LAEA-LAE-H-LAEA-LAEA-LEALAAC-
COOH were synthesized by GenScript (Piscataway, NJ 
USA) and used without any further purification step. 
Lysotraker™ RED (L7528) was purchased form Ther-
mofisher. Saporin (S9896), calcein (21030, Fluka) and 
Rhodamine 123 (R8004) were purchased from Sigma 
Aldrich.
Conjugation of the cysteine‑containing 
peptides with the lipid 
1,2‑dipalmitoyl‑sn‑glycero‑3‑phospho‑thio‑ethanol
The conjugated lipopeptides were synthetized in two 
steps. The first step consists on the activation of the thiol 
group of the lipid 1,2-dipalmitoyl-sn-glycero-3-phospho-
thioethanol (DPTE; Avanti Lipids) and the second step 
is the conjugation of the reactive dissymmetric disulfide 
DPTE (aDPTE) with the cysteine residue of the tbFGF 
and GALA-Cys peptides (GenScript, Piscataway, NJ 
USA). In more detail, 200  mg (275  μmol) of DPTE and 
120 mg (550 μmol) of 2,2′-dipyridyldisulfide (DPDS) were 
first dissolved in methanol:acetic acid (MeOH:AcOH 
160:1, v/v), in a final volume of 4 ml and incubated under 
stirring for 48 h at RT in the dark. For the second reac-
tion, 5 mg (6 μmol) of aDPTE was incubated with 40 mg 
(40  μmol) of tbFGF or 120  mg (40  μmol) of GALA-Cys 
(1:7  mol:mol aDPTE:peptide ratio) in a mixture of tet-
rahydrofuran (THF) and 1 M Tris HCl pH 9 (2:1; vol:vol) 
in a final volume of 3 ml and stirred for 48 h at 20 °C in 
the dark. The release of mercaptopyridine in both reac-
tions was monitored spectrophotometrically (Genesis 
10 spectrophotometer; Fisher Scientific) at 362 nm. The 
absorption spectra of the reaction mixture were recorded 
during incubation at 20  °C in disposable cuvettes with 
an optical path of 1 cm from 300 nm to 500 nm with a 
spectral resolution of 1.0 nm and a scan rate of 200 nm/
min. The reaction takes place within the first 10  min 
where mercaptopyridine is released very fast, but is left 
up to 48 h to ensure complete reaction of the substrates. 
During the synthesis, samples were analyzed by thin layer 
chromatography by comparing the  Rf values of reaction 
products with protein and lipid standards.
Thin layer chromatography
Preparative silica TLC [73] was used to remove mer-
captopyridine from conjugation reaction using acetone 
as the mobile phase. The mercaptopyridine runs in the 
acetone front leaving both, the aDPTE and the DPTE-
peptide, behind on the silica plate. Both the aDPTE 
and DPTE-peptide were scraped from the preparative 
TLC plate (Analtech, USA) and dissolved in 30  ml of 
chloroform and applied on a silica column for further 
purification.
Column preparation and elution
Silica Gel (Sigma-Aldrich), suspended in chloroform, was 
packed to a height of 30 cm column. Applying slight air 
pressure during packing resulted in a uniform distribu-
tion of adsorbent, which was supported and covered by 
small glass wool plugs. The scraped lipid-silica mixture 
was suspended in chloroform and applied to the pre-
packed column and washed with three column volumes 
of chloroform:methanol mixture  (CHCl3:MeOH; 9:1: v/v) 
to elute the lipid mixture into the column. The DPTE and 
DPTE-peptide will dissolve in the mobile phase whereas 
the silica will remain packed on the prepacked solid 
silica phase. Elution was carried out with three column 
volumes of  CHCl3:MeOH (13:5; v/v) at room tempera-
ture under slight air pressure. The eluate was collected in 
30 ml fractions and analyzed by TLC to detect the pres-
ence of DPTE or DPTE-peptide. Lipids were visualized 
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with the molybdic oxide–molybdenum “Zinzadze” phos-
phorus staining reagent [74]. The fractions containing 
the aDPTE or DPTE-peptide were pooled individually, 
the solvents evaporated under nitrogen and the residual 
lipids or conjugates stored at − 20  °C until further use. 
The lipid and protein content of the obtained products 
were determined according to Rouser [33] and Lowry 
[34] respectively to calculate the efficiency of synthesis. 
The synthesized products (aDPTE and DPTE-peptide) 
were characterized by 1 H NMR spectroscopy (NMR 
CAI; Universidad Complutense Madrid).
Preparation of liposomes
Liposomes were prepared according to the standard 
thin-film hydration method [75]. For the different formu-
lations used here, the lipid and DPTE-peptide contain-
ing chloroform solutions were mixed and dried using a 
vacuum concentrator (Eppendorf ). Dried films were then 
hydrated with 500 µl of in  Ca2+ and  Mg2+ free PBS (the 
final lipid concentration was 1 mg/ml) and vortexed for 
10 min facilitating hydration of the lipids and the forma-
tion or multilamellar lipid vesicles (MLVs). After hydra-
tion the sample was extruded through a polycarbonate 
membrane (100 nm pore size; Avanti lipids) and exposed 
to MEFs grown in DMEM (see “Cell cultures”) for viabil-
ity, uptake and release assays. For confocal experiments, 
calcein (100 mM) was added to buffer prior to rehydra-
tion step. Calcein containing MLVs were dispersed by 
vortexing (5 min) and sonication of the turbid suspension 
up to 20 min. Liposomes were washed trice with 40 mM 
HEPES by ultracentrifugation (Beckmann, TLA120 
rotor, 100,000×g, 60  min) and resuspended in a final 
volume of 500 µl of 50 mM HEPES, 150 mM KCl, pH 8 
for lipid-mixing assays or  Ca2+ and  Mg2+ free PBS for 
cell assays. For ATP and saporin delivery experiments, 
the lipid film was rehydrated in the presence of 0  mM 
(control), 10  mM, 25  mM 50  mM and 100  mM of ATP 
buffered in 1  M HEPES pH 7.2 or 75  μg/ml of saporin 
buffered in 100 mM HEPES pH 7.2. ATP or saporin con-
taining MLVs were dispersed by vortexing (5  min) and 
sonicated up to 20  min until they became transparent. 
Liposomes were washed trice with 1 M HEPES pH 7.2 or 
in 100 mM HEPES pH 7.2 by ultracentrifugation (Beck-
mann, TLA120 rotor, 100,000×g, 60  min) and resus-
pended in a final volume of 100 µl of 1 M HEPES pH 7.2 
or in 100 mM HEPES pH 7.2 at a final lipid concentra-
tion of 1 mg/ml. The final concentration upon incubation 
with MEFs was achieved after further dilution in DMEM 
media.
Chemical analysis, DLS and zeta potential of liposomes
The lipid and lipopeptide content of liposomes before 
and after extrusion were also determined according to 
Rouser [33] and Lowry [34]. The diameters and the zeta-
potential of the liposomes were measured as a function 
of the molar ratio of lipopeptides by dynamic light scat-
tering (DLS) and electrophoretic mobility measurements 
in a 90 Plus Particle Analyzer (Brookhaven Instruments).
Liposomes fusion assay
15 mM POPC/DPTE-GALA liposomes carrying increas-
ing amount of DPTE-GALA (1, 5% mol) loaded with cal-
cein at self-quenching concentration of 100  mM were 
incubated with empty 15  mM POPC liposomes (1:9 
vol:vol) and titrated with 0.1 M HCl to drop the external 
pH from 8 to 5.5. The fusion assay is based on the dilu-
tion of the lumenal calcein concentration that leads to 
an increase of the fluorescence signal. The fluorescence 
signal was monitored spectroscopically on an AMINCO-
Bowman Series 2 (AB2) Spectrofluorometer (emission 
wavelength of 520  nm upon excitation at 495  nm and 
slit width of 5  nm). The maximal calcein release of the 
POPC-DPTE-GALA liposomes was estimated after solu-
bilization of 1% of triton X-100 at pH 8 and 5.5.
Cell culture
The mouse embryonic fibroblasts (MEF; purchased from 
ATCC) were cultured in complete DMEM (high glu-
cose Dulbecco Modified Eagle Medium), 25  mM Glu-
cose (Gibco) supplemented with 10% fetal bovine serum 
(South Africa S1300; Biowest, Nuallé, France), penicillin/
streptomycin (final concentration 100 U/ml of penicil-
lin and 100  μg/ml of streptomycin respectively) and 1% 
of non-essential amino acids (all Gibco). The cells were 
grown in a humidified incubator (Forma Steri-Cycle The-
mofisher; 5%  CO2) at 37  °C and maintained, with split 
ratio of 1:20, at 80% of confluence in T75 flasks (Nunc).
Cell viability assays
The cell viability of treated MEFs was monitored with the 
Alamar Blue viability assay (Serotec, Oxon, UK) [76–78] 
according to manufacturer’s instructions. This cell viabil-
ity assay is based on a reazurin that reflects the redox 
state of the cell. In living cells, reazurin (7-Hydroxy-
3H-phenoxazin-3-one 10-oxide) is effectively reduced 
due to mitochondrial metabolic activity, where NADPH 
or NADH reduces the blue resazurin to the red resorufin 
[79]. Reazurin absorption was measured at 570  nm and 
data was corrected according to:
with λ1 = 570 nm and λ2 = 620 nm, εox = 80,586 L  mol−1 
 cm−1 at 570 nm, Aλ1 the absorption at 570 nm and Aλ2 
the absorption at 620  nm, the superscript º stands for 
the positive control well. MEFs were lifted and seeded in 
(1)
(εox)2A1 − (εox)1A2
(εox)2A
o
1 − (εox)1A
o
2
× 100
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96-well plates at a density of 3 × 103 cells/cm2. After 24 h 
of incubation at 37 °C with 5%  CO2 and 95% humidity in 
the cell incubator to allow cell attachment, 10  μl of the 
Alamar Blue reagent is added to each well of the 96-well 
plate and incubated for additional 2 h at 37  °C with 5% 
 CO2 and 95% humidity in the cell incubator. After incu-
bation, absorption of individual plate was measured at 
570  nm and 620  nm in a Multiskan™ FC (Thermo Sci-
entific™) plate reader. Data was analyzed with a two-way 
ANOVA (p-value < 0.05) relating cell death to the ratios 
of DPTE-GALA/DPTE-tbFGF and the total concentra-
tion of transfected liposomes (50, 75 and 100 μM) or ATP 
concentration.
Confocal laser scanning microscopy
Confocal laser scanning microscopy images were taken 
of MEFs seeded in a four-chamber  LabTeck® (C6807, 
Sigma-Aldrich) at a density of 1 × 105 cells per  cm2 
in complete DMEM and incubated for 24  h at 37  °C. 
Before microscopy MEFs were washed twice with HBBS 
and incubated in complete DMEM medium containing 
100  μM of liposomes. Cells were imaged at 2, 4 and/or 
6  h after liposome incubation. The  LabTeck® chamber 
was mounted on a stage of a Nikon Ti-E inverted micro-
scope at 37  °C equipped with a Nikon C2 confocal spot 
microscope, Nikon Plan Apo 100× NA oil immersion 
objective 1.45 UV filter cubes-2E/C (excitation band 
340–380 nm, emission band 435–485 nm), B-2E/C (exci-
tation band: 465–495  nm, emission band: 515–555  nm 
and Y-2E/C (excitation band: 540–580  nm, emission 
band: 600–660  nm). Images were captured with Nikon 
NIS-Elements software and processed with ImageJ soft-
ware package [80].
Luciferase assay
Intracellular ATP and encapsulated ATP in the liposome 
were quantified using ATP Determination Kit (Thermo 
Fisher Scientific, USA) and performed according to 
manufacturer instructions. For ATP or ATP encapsu-
lated liposome treatment, MEFs were grown on 96-well 
plate by seeding 1.5 × 104 cells/well. After 24 h of incuba-
tion at 37 °C with 5%  CO2 and 95% humidity in the cell 
incubator each well was treated with 100  µl of DMEM 
with appropriate concentration of ATP or liposome and 
measured the intracellular ATP at different time points. 
For quantification of ATP, the cells were washed three 
times with PBS to remove the unbound ATP. Thereaf-
ter 100  µl lysis buffer (0.2  M borate buffer, 0.1% Triton 
X100, pH 9.2) was added to each well and the plates were 
kept at room temperature for 10 min. The resultant lysate 
was further diluted with 200  µl lysis buffer then trans-
ferred to a 1.5  ml eppendorf tube. The cellular debris 
were removed by centrifugation at 13,500×g and 4 °C for 
10 min and supernatant were transferred to new eppen-
dorf tube. 10  µl of the supernatant was used for ATP 
determination assay. To determine the encapsulated ATP 
in the liposome, 50 µl liposomes were lysed using 50 µl 
lysis buffer as mentioned above, incubated for 10  min 
and then diluted three-fold by the addition of 200 µl lysis 
buffer. 10 µl of lysate was used to determine the ATP con-
centration. Luminescence assay was performed with a 
white 96-well plate and luminescence was measured with 
a microplate reader at 560 nm (BMG Labtech, Germany).
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